ArticleFrontiers in pediatrics2016

Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS.

Dai Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.